Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3540)
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
3,056
Price
$18.03
Total Value
$55.10K
Shares Held After
1,571,214
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
68
Price
$158.11
Total Value
$10.75K
Shares Held After
1,666
% of Holdings
3.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
155
Price
$157.29
Total Value
$24.38K
Shares Held After
1,734
% of Holdings
8.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
121
Price
$156.53
Total Value
$18.94K
Shares Held After
1,889
% of Holdings
6.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
173
Price
$155.48
Total Value
$26.90K
Shares Held After
2,010
% of Holdings
7.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
363
Price
$154.44
Total Value
$56.06K
Shares Held After
2,183
% of Holdings
14.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
120
Price
$153.92
Total Value
$18.47K
Shares Held After
2,546
% of Holdings
4.5%
Ultragenyx Pharmaceutical Inc. (RARE)
Crombez Eric — EVP and Chief Medical Officer
Shares
344
Price
$24.96
Total Value
$8.59K
Shares Held After
111,189
% of Holdings
0.3%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
233
Price
$228.18
Total Value
$53.17K
Shares Held After
0
% of Holdings
100.0%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
582
Price
$17.18
Total Value
$10.00K
Shares Held After
37,592
% of Holdings
1.5%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
13,473
Price
$16.58
Total Value
$223.32K
Shares Held After
38,174
% of Holdings
26.1%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$77.37
Total Value
$270.80K
Shares Held After
153,902
% of Holdings
2.2%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
11,333
Price
$77.25
Total Value
$875.47K
Shares Held After
58,555
% of Holdings
16.2%
CYTOKINETICS INC (CYTK)
HENDERSON JOHN T — Director
Shares
20,000
Price
$75.97
Total Value
$1.52M
Shares Held After
75,237
% of Holdings
21.0%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
23,906
Price
$76.87
Total Value
$1.84M
Shares Held After
63,221
% of Holdings
27.4%
CYTOKINETICS INC (CYTK)
WIERENGA WENDELL — Director
Shares
4,032
Price
$75.00
Total Value
$302.40K
Shares Held After
32,637
% of Holdings
11.0%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
50,000
Price
$38.57
Total Value
$1.93M
Shares Held After
4,367
% of Holdings
92.0%
Spero Therapeutics, Inc. (SPRO)
Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Shares
25,240
Price
$2.51
Total Value
$63.35K
Shares Held After
986,851
% of Holdings
2.5%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
116,904
Price
$13.97
Total Value
$1.63M
Shares Held After
744,683
% of Holdings
15.7%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,900
Price
$13.90
Total Value
$54.20K
Shares Held After
627,779
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
787
Price
$30.12
Total Value
$23.70K
Shares Held After
377,723
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
325
Price
$29.56
Total Value
$9.61K
Shares Held After
378,510
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
8,989
Price
$28.28
Total Value
$254.21K
Shares Held After
378,835
% of Holdings
2.3%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
4,803
Price
$27.36
Total Value
$131.41K
Shares Held After
387,824
% of Holdings
1.2%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
705
Price
$30.08
Total Value
$21.21K
Shares Held After
279,356
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
320
Price
$29.56
Total Value
$9.46K
Shares Held After
280,061
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
700
Price
$30.08
Total Value
$21.06K
Shares Held After
385,125
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
5,526
Price
$28.37
Total Value
$156.77K
Shares Held After
280,381
% of Holdings
1.9%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
312
Price
$29.56
Total Value
$9.22K
Shares Held After
385,825
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
5,460
Price
$28.37
Total Value
$154.90K
Shares Held After
386,137
% of Holdings
1.4%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
9,250
Price
$27.50
Total Value
$254.38K
Shares Held After
285,907
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
9,180
Price
$27.50
Total Value
$252.45K
Shares Held After
391,597
% of Holdings
2.3%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
697
Price
$30.08
Total Value
$20.97K
Shares Held After
1,614,993
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
683
Price
$30.08
Total Value
$20.54K
Shares Held After
176,248
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
311
Price
$29.56
Total Value
$9.19K
Shares Held After
1,615,690
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
296
Price
$29.56
Total Value
$8.75K
Shares Held After
176,931
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
5,427
Price
$28.37
Total Value
$153.96K
Shares Held After
1,616,001
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
3,908
Price
$28.29
Total Value
$110.56K
Shares Held After
177,227
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
9,136
Price
$27.50
Total Value
$251.24K
Shares Held After
1,621,428
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
9,030
Price
$27.50
Total Value
$248.32K
Shares Held After
181,135
% of Holdings
4.7%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
20,000
Price
$45.00
Total Value
$900.00K
Shares Held After
111,473
% of Holdings
15.2%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
20,000
Price
$45.00
Total Value
$900.00K
Shares Held After
105,211
% of Holdings
16.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
884
Price
$23.61
Total Value
$20.87K
Shares Held After
126,689
% of Holdings
0.7%
Travere Therapeutics, Inc. (TVTX)
Meckler Jeffrey A — Director
Shares
8,000
Price
$45.00
Total Value
$360.00K
Shares Held After
87,500
% of Holdings
8.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
7,372
Price
$23.27
Total Value
$171.54K
Shares Held After
127,573
% of Holdings
5.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
3,172
Price
$23.61
Total Value
$74.89K
Shares Held After
720,755
% of Holdings
0.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
1,341
Price
$23.61
Total Value
$31.66K
Shares Held After
86,413
% of Holdings
1.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: EVP, Chief Medical Officer
Shares
684
Price
$23.61
Total Value
$16.15K
Shares Held After
120,466
% of Holdings
0.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
2,466
Price
$18.00
Total Value
$44.39K
Shares Held After
1,156,457
% of Holdings
0.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
61
Price
$18.00
Total Value
$1.10K
Shares Held After
8,450
% of Holdings
0.7%
Showing 1251–1300 of 3540 transactions (page 26 of 71)